Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Routine genetic testing is crucial for early diagnosis and better management of Turner’s syndrome with 21-hydroxylase deficiency.

Temporal triangular alopecia is a non-scarring hair loss seen in some Asian children.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

High doses of cyclosporine A increase testosterone conversion, possibly boosting hair growth.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

Trichoscopy can reliably distinguish between alopecia areata and trichotillomania.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

CT60 polymorphism might increase the risk of Alopecia Areata.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Ritlecitinib is an effective new treatment for Alopecia Areata.

MsPG3 protein gathers at root hair tips, aiding growth.

A patient with a rare disease had a unique genetic mutation linked to their symptoms.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

A super thin DIEP flap can effectively reconstruct scalp defects with good skin coverage and contour.